BioNTech to Close Tübingen Site by End of 2027, Impacting Over 700 Jobs
BioNTech plans to shut its Tübingen site by the end of 2027, impacting 700+ jobs due to reduced COVID-19 vaccine demand and lack of investors.
Vaccine
All vaccine news
BioNTech to Close Three German Production Sites, Affecting 1,800 Jobs Amid Strategic Shift
BioNTech announces closure of three German production sites by early 2028, impacting 1,800 jobs, as it pivots towards oncology and faces declining COVID-19 vaccine demand.
Bundesrat Approves Key Pharmacy Reform and Hospitals in Halle Boost Medical Collaboration
Germany's Bundesrat has approved pharmacy reforms expanding vaccination and medication services, while hospitals in Halle announce a multi-million euro collaboration to improve regional healthcare.
WHO Approves First Malaria Medication Specifically for Babies in Africa
The WHO has approved a new malaria medication intended specifically for babies in Africa, closing a vital treatment gap and promoting safer care.
Gender-Specific Medicine Key to Healthier Aging for Women in Germany
Women in Germany live longer than men but face unique health challenges as they age, underscoring the need for gender-specific medicine and improved vaccination efforts to reduce cardiovascular risks triggered by infections.